Last updated on June 2018

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis


Brief description of study

B7451015 is a Phase 3 study to evaluate PF-04965842 with or without Topical Medications in patients aged 12 years and older with a minimum body weight of 40 kg who have moderate to severe atopic dermatitis and have completed a qualifying Phase 3 study. The efficacy and safety of two dosage strengths of PF-04965842, 100 mg and 200 mg taken orally once daily, will be evaluated over approximately two years of study participation. Patients who meet safety step-down criteria will have their dose reduced once, from 200 mg QD to 100 mg QD, or from 100 mg QD to placebo.

Clinical Study Identifier: NCT03422822

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

California Dermatology & Clinical Research Institute
Encinitas, CA United States
  Connect »

Pfizer CT.gov Call Center

Clinical Research Center of Alabama, LLC
Birmingham, AL United States
  Connect »

Pfizer CT.gov Call Center

Clinical Science Institute
Santa Monica, CA United States
  Connect »

Pfizer CT.gov Call Center

Florida Academic Centers Research and Education, LLC
Coral Gables, FL United States
  Connect »

Pfizer CT.gov Call Center

Forward Clinical Trials, Inc.
Tampa, FL United States
  Connect »

Pfizer CT.gov Call Center

NorthShore University HealthSystem Dermatology Clinical Trials Unit
Skokie, IL United States
  Connect »

Pfizer CT.gov Call Center

Dawes Fretzin Clinical Research Group, LLC
Indianapolis, IN United States
  Connect »

Pfizer CT.gov Call Center

Dawes Fretzin Dermatology Group, LLC
Indianapolis, IN United States
  Connect »

Pfizer CT.gov Call Center

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK United States
  Connect »

Pfizer CT.gov Call Center

Arlington Research Center, Inc.
Arlington, TX United States
  Connect »

Pfizer CT.gov Call Center

Tekton Research, Inc.
Austin, TX United States
  Connect »

Pfizer CT.gov Call Center

Virginia Clinical Research, Inc
Norfolk, VA United States
  Connect »

Pfizer CT.gov Call Center

Meridian Clinical Research, LLC
Savannah, GA United States
  Connect »

Pfizer CT.gov Call Center

Lynn Health Science Institute
Oklahoma City, OK United States
  Connect »

Pfizer CT.gov Call Center

Somerset Skin Centre
Troy, MI United States
  Connect »

Pfizer CT.gov Call Center

TCR Medical Corporation
San Diego, CA United States
  Connect »

Pfizer CT.gov Call Center

Australian Clinical Research Network
Maroubra, Australia
  Connect »

Pfizer CT.gov Call Center

Spectrum Medical Imaging
Maroubra, Australia
  Connect »